Eclipsys boosts patient flow solutions with Premise purchase

  
Eclipsys adds to patient flow solutions with Premise purchase. Image Source: Eclipsys 
Eclipsys has signed a definitive agreement to acquire all of the outstanding equity interests of Premise, a privately held provider of patient flow software solutions.

The agreement was reached by the Atlanta-based Eclipsys and certain stockholders of Premise on Dec. 30, 2008, and provides for a purchase price of $38.5 million cash, subject to certain holdback escrow provisions and working capital adjustments.

The transaction, which has been approved by the boards of directors of Eclipsys and Premise, is expected to close within next 15 days, subject to satisfaction of customary closing conditions, according to Eclipsys.

The Farmington, Conn.-based Premise provides integrated and clinical software solutions and services that optimize patient flow and streamline communications, including systems for bed management, bed turnover, transport and decision support.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.